Cancer-fighting East Bay company upsizes IPO, raises $120 million
March 15, 2018 at 10:40 AM EDT
Initially backed by Alphabet's GV unit, Stanford University, The Column Group and others, the Hayward company is looking for next-generation ways to stimulate the immune system to fight cancer.
